June 30 (Reuters) - AMAG Pharmaceuticals Inc:

* FDA approves Feraheme to treat iron deficiency anemia in adult chronic

kidney disease patients

* Says product launch expected in the second half of July 2009

* Says will conduct two post-marketing studies in the pediatric chronic kidney

disease population

* Sees commencing these studies in 2010

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

(For more news, please click here)

COPYRIGHT

Copyright Thomson Reuters 2009. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.